Pharmafile Logo

Free Thinking – US Presidential Election: The legacy of the Affordable Care Act and the future for healthcare

October 31, 2016 | US healthcare 

Our latest Free Thinking white paper explores the legacy of the Affordable Care Act and the future for healthcare

Our latest Free Thinking white paper explores the legacy of the Affordable Care Act and the future for healthcareAs US citizens prepare to vote for a new President on Tuesday 8th November, we ask, what is the likely impact of a Republican or Democrat win on the future of the ACA, the health system and the pharma industry?

We spoke to John Leifer, author and strategic consultant to the healthcare industry, to see which way he thinks the wind is blowing. 

Download our complimentary Free Thinking white paper which looks at:

– The Affordable Care Act: in principle and practice
– Where the candidates stand
– The impact of recent pricing scandals
– The effect on pharma
– The need to demonstrate real long-term value

http://www.researchpartnership.com/news/2016/10/free-thinking-us-presidential-election-future-for-he…

This content was provided by Research Partnership

Company Details

 Latest Content from  Research Partnership 

Webcast:

UX beyond the website: Insights for the age of omnichannel

News:

MedTech Qualitative Specialist joins Research Partnership

Guide

How to embrace behavioural science principles in healthcare MR

Article

A glimmer of hope for Alzheimer’s patients, but at what cost?

Video

Virtual Conference Live

Report

Digital Health Tools - Physician Trends

Webcast

Oncology landscape: How innovative market research methods can navigate you to success

Article:

The disparity of patient experiences with Crohn’s Disease in Europe and Japan

Research Partnership’s MedTech Division appoints two Directors

Chris Carles has joined as a Director in our Philadelphia office and Andrew Way as a Research Director in our UK office.

Webcast: Influencing HCP behaviours – Is now the perfect opportunity?

Putting behavioural science at the forefront of market research